EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $15,000 | -6.2% | 358 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | -15.8% | 358 | +14.7% | 0.00% | 0.0% |
| Q4 2019 | $19,000 | +5.6% | 312 | -1.0% | 0.00% | 0.0% |
| Q3 2019 | $18,000 | 0.0% | 315 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $18,000 | +12.5% | 315 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $16,000 | +23.1% | 315 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $13,000 | -7.1% | 315 | +57.5% | 0.00% | -50.0% |
| Q3 2018 | $14,000 | +40.0% | 200 | 0.0% | 0.01% | +100.0% |
| Q3 2017 | $10,000 | -99.9% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $16,000,000 | +114185.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $14,000 | -56.2% | 200 | -92.0% | 0.00% | -50.0% |
| Q3 2014 | $32,000 | +23.1% | 2,500 | 0.0% | 0.01% | -57.1% |
| Q2 2014 | $26,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |